Cargando…
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
AIMS/HYPOTHESIS: Some studies have reported that annual change in eGFR (eGFR slope) is associated with the future risk of end-stage kidney disease, cardiovascular disease and death in general or chronic kidney disease cohorts. However, the benefits of using eGFR slopes for prediction of major clinic...
Autores principales: | Oshima, Megumi, Jun, Min, Ohkuma, Toshiaki, Toyama, Tadashi, Wada, Takashi, Cooper, Mark E., Hadjadj, Samy, Hamet, Pavel, Harrap, Stephen, Mancia, Giuseppe, Marre, Michel, Williams, Bryan, Chalmers, John, Woodward, Mark, Perkovic, Vlado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805825/ https://www.ncbi.nlm.nih.gov/pubmed/31302707 http://dx.doi.org/10.1007/s00125-019-4948-4 |
Ejemplares similares
-
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020) -
History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021) -
Associations between body mass index and the risk of renal events in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2018) -
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
por: Harris, Katie, et al.
Publicado: (2020) -
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)